Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

COVID-19 increased alopecia areata relapses due to inflammation and stress.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Allergies and atopic conditions may increase the risk of developing alopecia areata.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Researchers developed an algorithm for self-diagnosing scalp conditions with high accuracy using smart device-attached microscopes.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Current treatments for Alopecia Areata are unsatisfactory and need improvement.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

The AI model accurately classifies Alopecia Areata with 96.94% accuracy.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The criteria help doctors diagnose and treat alopecia areata more effectively.

Researchers found four genes that could help diagnose severe alopecia areata early.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

People with alopecia areata often have lower vitamin D levels than healthy people.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Alopecia areata is more common in young Black African males, with rare other health issues.

A machine learning model can predict alopecia areata early using specific gene markers.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.